News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
SAXE JON S
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/24/2020 |
4
| SAXE JON S (Director) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Bought 30,000 shares
@ $0.69, valued at
$20.7k
|
|
| 06/18/2020 |
4
| SAXE JON S (Director) has filed a Form 4 on DURECT CORP|
Txns:
| Granted 55,000 options to buy
@ $2.33, valued at
$128.2k
|
|
| 04/27/2020 |
4
| SAXE JON S (Director) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 75,000 options to buy
@ $0.398, valued at
$29.9k
|
|
| 10/22/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/20/2019 |
4
| SAXE JON S (Director) has filed a Form 4 on DURECT CORP|
Txns:
| Granted 55,000 options to buy
@ $0.5818, valued at
$32k
|
|
| 06/11/2019 |
4
| SAXE JON S (Director) has filed a Form 4 on DURECT CORP|
Txns:
| Bought 287 shares
@ $0.5428, valued at
$155.8
Bought 1,200 shares
@ $0.5438, valued at
$652.6
Bought 200 shares
@ $0.5439, valued at
$108.8
Bought 15 shares
@ $0.544, valued at
$8.2
Bought 300 shares
@ $0.5443, valued at
$163.3
Bought 100 shares
@ $0.5444, valued at
$54.4
Bought 7,898 shares
@ $0.5449, valued at
$4.3k
Bought 100 shares
@ $0.5451, valued at
$54.5
Bought 1,751 shares
@ $0.5454, valued at
$955
Bought 300 shares
@ $0.5455, valued at
$163.7
Bought 1,400 shares
@ $0.5459, valued at
$764.3 |
|
| 05/28/2019 |
4
| SAXE JON S (Director) has filed a Form 4 on DURECT CORP|
Txns:
| Bought 4,065 shares
@ $0.63, valued at
$2.6k
Bought 21,335 shares
@ $0.6301, valued at
$13.4k
Bought 4,600 shares
@ $0.6302, valued at
$2.9k
|
|
| 05/28/2019 |
4
| SAXE JON S (Director) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1, valued at
$50k
|
|
| 05/15/2019 |
4
| SAXE JON S (Director) has filed a Form 4 on DURECT CORP|
Txns:
| Bought 900 shares
@ $0.7043, valued at
$633.9
Bought 6,500 shares
@ $0.7048, valued at
$4.6k
Bought 2,200 shares
@ $0.708, valued at
$1.6k
|
|
| 05/14/2019 |
4
| SAXE JON S (Director) has filed a Form 4 on DURECT CORP|
Txns:
| Bought 200 shares
@ $0.6804, valued at
$136.1
Bought 380 shares
@ $0.6802, valued at
$258.5
Bought 2,995 shares
@ $0.6803, valued at
$2k
Bought 287 shares
@ $0.6814, valued at
$195.6
Bought 900 shares
@ $0.6815, valued at
$613.4
Bought 699 shares
@ $0.685, valued at
$478.8
Bought 200 shares
@ $0.6881, valued at
$137.6
Bought 3,100 shares
@ $0.6898, valued at
$2.1k
Bought 1,195 shares
@ $0.69, valued at
$824.6
Bought 489 shares
@ $0.6902, valued at
$337.5
Bought 569 shares
@ $0.6906, valued at
$393 |
|
| 03/15/2019 |
4
| SAXE JON S (Director) has filed a Form 4 on DURECT CORP|
Txns:
| Bought 900 shares
@ $0.8172, valued at
$735.5
Bought 100 shares
@ $0.8169, valued at
$81.7
Bought 100 shares
@ $0.8168, valued at
$81.7
Bought 800 shares
@ $0.8167, valued at
$653.4
Bought 200 shares
@ $0.8165, valued at
$163.3
Bought 100 shares
@ $0.8163, valued at
$81.6
Bought 100 shares
@ $0.8161, valued at
$81.6
Bought 600 shares
@ $0.816, valued at
$489.6
Bought 200 shares
@ $0.8159, valued at
$163.2
Bought 200 shares
@ $0.8158, valued at
$163.2
Bought 300 shares
@ $0.8153, valued at
$244.6 |
|
| 03/15/2019 |
4
| SAXE JON S (Director) has filed a Form 4 on DURECT CORP|
Txns:
| Bought 400 shares
@ $0.825, valued at
$330
Bought 200 shares
@ $0.8236, valued at
$164.7
Bought 500 shares
@ $0.8235, valued at
$411.8
Bought 100 shares
@ $0.8234, valued at
$82.3
Bought 100 shares
@ $0.8233, valued at
$82.3
Bought 2,400 shares
@ $0.823, valued at
$2k
Bought 386 shares
@ $0.8226, valued at
$317.5
Bought 100 shares
@ $0.8225, valued at
$82.3
Bought 100 shares
@ $0.8223, valued at
$82.2
Bought 100 shares
@ $0.8222, valued at
$82.2
Bought 400 shares
@ $0.8218, valued at
$328.7 |
|
| 03/14/2019 |
4
| SAXE JON S (Director) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Bought 12,080 shares
@ $1.2584, valued at
$15.2k
Bought 7,920 shares
@ $1.2735, valued at
$10.1k
|
|
| 01/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/31/2018 |
4
| SAXE JON S (Director) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Disposed/sold 375 options to buy
@ $10, valued at
$3.8k
Granted 375 options to buy
@ $1.5, valued at
$562.5
Disposed/sold 1,000 options to buy
@ $10, valued at
$10k
Granted 1,000 options to buy
@ $1.5, valued at
$1.5k
Disposed/sold 7,500 options to buy
@ $10, valued at
$75k
Granted 7,500 options to buy
@ $1.5, valued at
$11.3k
Disposed/sold 2,500 options to buy
@ $10, valued at
$25k
Granted 2,500 options to buy
@ $1.5, valued at
$3.8k
Disposed/sold 25,000 options to buy
@ $3.49, valued at
$87.3k
Granted 25,000 options to buy
@ $1.5, valued at
$37.5k
Disposed/sold 25,000 options to buy
@ $3.8, valued at
$95k
|
|
| 08/06/2018 |
4
| SAXE JON S (Director) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 75,000 options to buy
@ $1.27, valued at
$95.3k
|
|
| 06/20/2018 |
4
| SAXE JON S (Director) has filed a Form 4 on DURECT CORP|
Txns:
| Granted 55,000 options to buy
@ $2.1, valued at
$115.5k
|
|
| 02/05/2018 |
4
| SAXE JON S (Director) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $1.16, valued at
$116k
|
|
| 10/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/20/2017 |
4
| SAXE JON S (Director) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.56, valued at
$78k
|
|
| 06/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/28/2017 |
4
| SAXE JON S (Director) has filed a Form 4 on VistaGen Therapeutics, Inc. |
| 02/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/10/2016 |
4
| SAXE JON S (Director) has filed a Form 4 on VistaGen Therapeutics, Inc. |
| 06/23/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/21/2016 |
4
| SAXE JON S (Director) has filed a Form 4 on VistaGen Therapeutics, Inc. |
| 06/13/2016 |
4
| SAXE JON S (Director) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Granted 30,000 options to buy
@ $13.995, valued at
$419.9k
|
|
| 04/04/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/28/2013 |
4
| SAXE JON S (Director) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Granted 30,000 options to buy
@ $5.13, valued at
$153.9k
|
|
|
|
|